Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. prescription drug spending as high as $610 billion by 2021: report

Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holdings.

Read More »

GSK’s Advair faces first direct competition

Teva Pharmaceutical Industries Ltd. launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline’s best-selling Advair.

Read More »

Trump Taps Congressman as Next ‘Drug Czar’

President Trump, hoping to take on the opioid epidemic sweeping parts of America, tapped U.S. Rep. Tom Marino to head up the Office of National Drug Control Policy.

Read More »

Changing the Learning Curve for Auto-Injection Therapy

As biologic medications administered through prefilled syringes continue to supplement and enter new therapeutic areas, more and more patients will need to embark on a learning curve that is possibly unlike any they have experienced prior.

Read More »

GSK’s new CEO gets short-term win from generic Advair delay

GlaxoSmithKline’s new CEO Emma Walmsley won a short-term reprieve from the threat of generic Advair with a delay in U.S. approval for Mylan’s copy of the blockbuster lung inhaler.

Read More »

U.S. lawmakers seek pricing info on DMD drug

Two U.S. lawmakers sent a letter to PTC Therapeutics Inc. seeking information about the drugmaker’s pricing strategy for its recently acquired muscle-wasting disorder drug.

Read More »

Harvoni Study: 97% of Hep C Patients Cured

Nearly all patients who completed at least eight weeks of hepatitis C treatment with Gilead’s Harvoni were cured of the disease, according to PBM Prime Therapeutics.

Read More »

Republicans revamp Obamacare bill

Congressional Republicans recrafted their Obamacare replacement bill in hopes of satisfying critics.

Read More »

CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects

CytomX Therapeutics and Bristol-Myers Squibb are strengthening their relationship with the expansion of a 2014 collaboration agreement. The companies announced a plan to include up to eight additional targets, six in oncology and two in non-oncology areas, using CytomX’s proprietary Probody platform.

Read More »

Trump backs House Republican healthcare plan

President Donald Trump backed a draft U.S. House of Reps’ Republican bill to repeal and replace the Obamacare healthcare law that is open to negotiation.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom